Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain
Journal of Fungi March 11, 2022 Elaine Meade, Sarah Hehir, Neil J. Rowan et al. 24 citations
Mushrooms have a long history of traditional medicinal use and are the primary natural source of psychedelic compounds. Growing interest focuses on using fungal active compounds like psychedelics to alleviate symptoms of mental health disorders such as major depressive disorder, anxiety, and addiction. The anxiolytic, antidepressant, and anti-addictive effects of these compounds have spurred neuropharmacological investigations. Micro-dosing or acute dosing with psychedelics like LSD and psilocybin may offer treatment options for patients who do not benefit from current therapies. Studies suggest that either dosing regimen produces a rapid and long-lasting effect with a good safety profile.